`

ImmPACT Bio

Biotechnology Research

Specialities :
Car-t
Immunotherapy
Cancer therapy
On target off tumor toxicity
Selective treatment

+7

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$8.0M
size-icon Size
51 - 200

Frequently Asked Questions About ImmPACT Bio

What does Immpact bio do?+

ImmPACT Bio USA, Inc., is a clinical-stage company dedicated to the discovery of transformative chimeric antigen receptor (CAR) T-cell therapies that address key biological challenges in treating cancer and autoimmune diseases. Our technology is designed to precisely distinguish cancer and diseased cells from normal cells; thereby eliminating them without damaging normal tissues. The company was founded in 2017 in the FuturRx incubator (Israel). In 2019, ImmPACT Bio was incorporated in the US. In 2021 ImmPACT Bio merged with Kalthera. In 2022 we moved our Corporate offices to West Hills, CA and built a state-of-the-art clinical manufacturing facility

What are Immpact bio's specialties? +

Car-t,immunotherapy,cancer therapy,on target off tumor toxicity ,selective treatment ,logic gate,oncology,biotechnology,research,immunotherapy,autoimmune,and lupus

What is Immpact bio's industry? +

Immpact bio operates in the Biotechnology research industry.

What is Immpact bio's revenue? +

Immpact bio's revenue is 11m - 100m

What is Immpact bio's company size? +

Immpact bio has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.